A detailed history of Wrapmanager Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wrapmanager Inc holds 11,883 shares of GILD stock, worth $792,477. This represents 0.24% of its overall portfolio holdings.

Number of Shares
11,883
Previous 10,728 10.77%
Holding current value
$792,477
Previous $869,000 0.12%
% of portfolio
0.24%
Previous 0.26%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$71.58 - $87.29 $82,674 - $100,819
1,155 Added 10.77%
11,883 $870,000
Q4 2023

Feb 07, 2024

BUY
$73.27 - $83.09 $30,846 - $34,980
421 Added 4.08%
10,728 $869,000
Q3 2023

Nov 06, 2023

SELL
$73.94 - $80.67 $13,531 - $14,762
-183 Reduced 1.74%
10,307 $772,000
Q2 2023

Aug 08, 2023

SELL
$76.01 - $86.7 $300,771 - $343,071
-3,957 Reduced 27.39%
10,490 $808,000
Q1 2023

May 08, 2023

SELL
$77.31 - $88.08 $767,069 - $873,929
-9,922 Reduced 40.72%
14,447 $1.2 Million
Q4 2022

Feb 06, 2023

BUY
$62.32 - $89.47 $66,557 - $95,553
1,068 Added 4.58%
24,369 $2.09 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $26,495 - $30,264
445 Added 1.95%
23,301 $1.44 Million
Q2 2022

Aug 05, 2022

BUY
$57.72 - $65.01 $99,740 - $112,337
1,728 Added 8.18%
22,856 $1.41 Million
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $142,599 - $178,691
2,462 Added 13.19%
21,128 $1.26 Million
Q4 2021

Feb 07, 2022

BUY
$64.88 - $73.64 $27,054 - $30,707
417 Added 2.29%
18,666 $1.36 Million
Q3 2021

Nov 10, 2021

SELL
$67.69 - $73.03 $19,088 - $20,594
-282 Reduced 1.52%
18,249 $1.28 Million
Q2 2021

Aug 04, 2021

BUY
$63.47 - $69.35 $178,794 - $195,358
2,817 Added 17.93%
18,531 $1.28 Million
Q1 2021

May 10, 2021

BUY
$60.0 - $68.46 $139,440 - $159,101
2,324 Added 17.36%
15,714 $1.02 Million
Q4 2020

Feb 08, 2021

SELL
$56.65 - $64.55 $101,573 - $115,738
-1,793 Reduced 11.81%
13,390 $780,000
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $441,034 - $554,524
7,102 Added 87.89%
15,183 $959,000
Q2 2020

Aug 11, 2020

SELL
$72.34 - $84.0 $894,918 - $1.04 Million
-12,371 Reduced 60.49%
8,081 $622,000
Q1 2020

May 08, 2020

BUY
$62.63 - $80.22 $156,700 - $200,710
2,502 Added 13.94%
20,452 $1.53 Million
Q4 2019

Feb 11, 2020

SELL
$61.62 - $67.78 $109,005 - $119,902
-1,769 Reduced 8.97%
17,950 $1.17 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $1.23 Million - $1.36 Million
19,719 New
19,719 $1.25 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $83.6B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wrapmanager Inc Portfolio

Follow Wrapmanager Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wrapmanager Inc with notifications on news.